294 related articles for article (PubMed ID: 18084281)
1. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.
Morishige M; Hashimoto S; Ogawa E; Toda Y; Kotani H; Hirose M; Wei S; Hashimoto A; Yamada A; Yano H; Mazaki Y; Kodama H; Nio Y; Manabe T; Wada H; Kobayashi H; Sabe H
Nat Cell Biol; 2008 Jan; 10(1):85-92. PubMed ID: 18084281
[TBL] [Abstract][Full Text] [Related]
2. The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis.
Sabe H; Hashimoto S; Morishige M; Ogawa E; Hashimoto A; Nam JM; Miura K; Yano H; Onodera Y
Traffic; 2009 Aug; 10(8):982-93. PubMed ID: 19416474
[TBL] [Abstract][Full Text] [Related]
3. The EGFR-GEP100-Arf6 pathway in breast cancer: Full invasiveness is not from the inside.
Sabe H; Hashimoto S; Morishige M; Hashimoto A; Ogawa E
Cell Adh Migr; 2008; 2(2):71-3. PubMed ID: 19262097
[TBL] [Abstract][Full Text] [Related]
4. GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway.
Hu Z; Xu R; Liu J; Zhang Y; Du J; Li W; Zhang W; Li Y; Zhu Y; Gu L
Exp Cell Res; 2013 Aug; 319(13):1932-1941. PubMed ID: 23747719
[TBL] [Abstract][Full Text] [Related]
5. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
6. GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis.
Hashimoto A; Hashimoto S; Ando R; Noda K; Ogawa E; Kotani H; Hirose M; Menju T; Morishige M; Manabe T; Toda Y; Ishida S; Sabe H
PLoS One; 2011; 6(8):e23359. PubMed ID: 21858086
[TBL] [Abstract][Full Text] [Related]
7. GEP100/Arf6 is required for epidermal growth factor-induced ERK/Rac1 signaling and cell migration in human hepatoma HepG2 cells.
Hu Z; Du J; Yang L; Zhu Y; Yang Y; Zheng D; Someya A; Gu L; Lu X
PLoS One; 2012; 7(6):e38777. PubMed ID: 22701712
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor-GEP100-Arf6 axis affects the prognosis of lung adenocarcinoma.
Oka S; Uramoto H; Shimokawa H; Yamada S; Tanaka F
Oncology; 2014; 86(5-6):263-70. PubMed ID: 24902879
[TBL] [Abstract][Full Text] [Related]
9. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation.
Li M; Wang J; Ng SS; Chan CY; He ML; Yu F; Lai L; Shi C; Chen Y; Yew DT; Kung HF; Lin MC
Cancer; 2009 Nov; 115(21):4959-72. PubMed ID: 19642173
[TBL] [Abstract][Full Text] [Related]
10. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
[TBL] [Abstract][Full Text] [Related]
11. Getting invasive with GEP100 and Arf6.
Valderrama F; Ridley AJ
Nat Cell Biol; 2008 Jan; 10(1):16-8. PubMed ID: 18172429
[No Abstract] [Full Text] [Related]
12. Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma.
Menju T; Hashimoto S; Hashimoto A; Otsuka Y; Handa H; Ogawa E; Toda Y; Wada H; Date H; Sabe H
PLoS One; 2011; 6(9):e25301. PubMed ID: 21966491
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner.
Liu ZB; Hou YF; Zhu J; Hu DL; Jin W; Ou ZL; Di GH; Wu J; Shen ZZ; Shao ZM
Oncogene; 2010 May; 29(20):2996-3009. PubMed ID: 20228837
[TBL] [Abstract][Full Text] [Related]
14. The guanine nucleotide exchange protein for ADP-ribosylation factor 6, ARF-GEP100/BRAG2, regulates phagocytosis of monocytic phagocytes in an ARF6-dependent process.
Someya A; Moss J; Nagaoka I
J Biol Chem; 2010 Oct; 285(40):30698-707. PubMed ID: 20601426
[TBL] [Abstract][Full Text] [Related]
15. CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.
Nam JM; Onodera Y; Mazaki Y; Miyoshi H; Hashimoto S; Sabe H
EMBO J; 2007 Feb; 26(3):647-56. PubMed ID: 17255943
[TBL] [Abstract][Full Text] [Related]
16. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
17. The Arf6 GEF GEP100/BRAG2 regulates cell adhesion by controlling endocytosis of beta1 integrins.
Dunphy JL; Moravec R; Ly K; Lasell TK; Melancon P; Casanova JE
Curr Biol; 2006 Feb; 16(3):315-20. PubMed ID: 16461286
[TBL] [Abstract][Full Text] [Related]
18. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling.
Yoon SO; Shin S; Lipscomb EA
Cancer Res; 2006 Mar; 66(5):2732-9. PubMed ID: 16510594
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
20. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
Kassis J; Moellinger J; Lo H; Greenberg NM; Kim HG; Wells A
Clin Cancer Res; 1999 Aug; 5(8):2251-60. PubMed ID: 10473113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
